首页> 外国专利> METHOD FOR PREDICTION OF MYOMATOUS ASSEMBLY EXPULSION FOLLOWING UTERINE ARTERY EMBOLIZATION IN A PATIENT WITH UTERINE MYOMA

METHOD FOR PREDICTION OF MYOMATOUS ASSEMBLY EXPULSION FOLLOWING UTERINE ARTERY EMBOLIZATION IN A PATIENT WITH UTERINE MYOMA

机译:子宫肌瘤患者子宫动脉栓塞后肌组织排斥的预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to gynecology, can be used for prediction of myomatous assembly expulsion following uterine artery embolization (UAE) in a patient with uterine myoma. That is ensured by immunohistochemical examination of biopsy material of myomatous node in a patient with uterine myoma before UAE. Following genes are measured: VEGF, CD-117, Desmin, Actin, Vimentin, Ki-67. If observing VEGF values of 40 %, CD-117 15 %, Desmin 100 %, Actin 100 %, Vimentin 100 % and Ki-67 10 %, the myomatosis unit is predicted to expel.;EFFECT: method enables selecting the optimal approach to administering the patients with hysteromyoma after the UAE, reducing the risk of bleeding, eliminating intra- and postoperative complications caused by the surgical intervention, while maintaining fertility in the patients of reproductive age.;1 cl, 2 ex
机译:技术领域本发明涉及医学,即妇科,可用于预测子宫肌瘤患者子宫动脉栓塞(UAE)后的肌瘤组装排出。在阿联酋接受子宫肌瘤的患者中,通过免疫组织化学检查子宫肌瘤的活检材料可以确保这一点。测量以下基因:VEGF,CD-117,结蛋白,肌动蛋白,波形蛋白,Ki-67。如果观察到VEGF值分别为40%,CD-117 15%,结蛋白100%,肌动蛋白100%,波形蛋白100%和Ki-67 10%,则可以预测肌瘤形成单位被排出。在阿联酋接受子宫肌瘤患者治疗,降低出血风险,消除手术干预引起的术中和术后并发症,同时保持育龄患者的生育能力。; 1 cl,2 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号